In addition to EMT activation, β-catenin, proliferation-related genes c-Myc and cyclin D1, and cancer stem cell marker Nanog were markedly upregulated in HCC cells exposed to CM from NE-treated LX2 (Fig. 2b; Additional file 4: Fig. S3). The gene discussed is NANOG; the disease is hepatocellular carcinoma.